Stay updated with breaking news from Daniel Janney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) saw a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,330,000 shares, a decline of 7.6% from the July 15th total of 1,440,000 shares. Based on an average daily trading volume, of 324,300 shares, the short-interest […]
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price target lifted by Chardan Capital from $148.00 to $153.00 in a research note released on Monday, Marketbeat.com reports. They currently have a buy rating on the stock. Chardan Capital also issued estimates for Krystal Biotech’s FY2023 earnings at ($5.22) EPS and FY2024 earnings at $2.75 EPS. […]
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) traded up 2.3% during mid-day trading on Thursday . The stock traded as high as $122.01 and last traded at $122.01. 109,183 shares changed hands during trading, a decline of 57% from the average session volume of 254,385 shares. The stock had previously closed at $119.29. […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $131.80 and last traded at $130.90, with a volume of 12127 shares. The stock had previously closed at $130.32. Wall Street Analysts Forecast Growth A number of equities analysts have weighed in […]
Verition Fund Management LLC boosted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) by 19.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,561 shares of the company’s stock after purchasing an additional 12,909 shares during the […]